Skip to main content
← All data ties

Diabetes, Digestive, And Kidney Diseases Extramural Research in FY2026

$437,079,226.28 in USAspending.gov obligations sit on Diabetes, Digestive, And Kidney Diseases Extramural Research (CFDA 93.847) in fiscal year 2026, across 291 awards. DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH is CFDA 93.847. FY2026 is about 2.5 percent of a $17.28 billion extract, not the full 93.847 book. This page is that program–year join, not a clinic census, a named-PI roster, or a patient-enrollment file. Obligations are not outlays.

Key figures

  • Diabetes, Digestive, And Kidney Diseases Extramural Research in FY2026: $437,079,226.28 in USAspending obligations (CFDA 93.847).
  • FY2026 obligations of $437,079,226.28 sit below the CFDA program total of $17,283,124,047.25.
  • The FY2026 table lists 291 awards, not a census of diabetes or kidney studies.
  • The join is Diabetes, Digestive, And Kidney Diseases Extramural Research × FY2026, not a campus ranking or a named NIDDK-grantee list.
  • Figures are obligations, not outlays; FEC donations do not fund this total.

NIDDK Extramural Research overlapping FY2026 — CFDA 93.847

The pair is Diabetes, Digestive, And Kidney Diseases Extramural Research × FY2026. $437,079,226.28 is the obligation aggregate for rows that carry both CFDA 93.847 and fiscal year 2026 on the yearlyTrend table. The FY2026 obligation $437,079,226.28 is 2.5% of the CFDA program total of $17,283,124,047.25. This page does not invent the other fiscal-year rows that sit outside FY2026 on NIDDK Extramural Research. Correlation is not causation: the join does not prove that FY2026 caused NIDDK Extramural Research activity, only that USAspending coded the two keys together. It is not a campus ranking or a named NIDDK-grantee list.

SpendingVault indexes the cell from USAspending.gov. The catalog title on the program side is DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH. The year on the other side is federal fiscal year 2026. Neither label is a contractor, a place of performance, or an awarding-agency code — this packet publishes no awarding agency and no named recipients. Cite $437,079,226.28 as obligations on the NIDDK Extramural Research–FY2026 pair. Two hundred ninety-one FY2026 awards on $437 million sit far below the program-wide 7,632-award extract; other years stay on the program hub.

CFDA 93.847 as the NIDDK extramural-research side

CFDA 93.847 is the Catalog of Federal Domestic Assistance identifier for Diabetes, Digestive, And Kidney Diseases Extramural Research. The program-wide obligation total in this extract is $17,283,124,047.25 across 7,632 awards. That figure is a program rollup, not a second headline for the FY2026 cell unless the two amounts match. Do not treat $17,283,124,047.25 as cash Treasury already sent. Institute names, protocol IDs, and investigator lists are unpublished on this packet.

FY2026 as the 93.847 yearlyTrend cell

Federal fiscal year 2026 is the time key on this yearlyTrend row. The year hub FY2026 federal spending at /fiscal-years/2026/ rolls up every program that year in the index, not only NIDDK Extramural Research. Reading $437,079,226.28 as all FY2026 federal obligations would over-read this cell. The join is one CFDA inside one fiscal year, not a Budget Appendix score.

Do not add Federal Election Commission contribution totals to $437,079,226.28. Campaign-finance receipts and USAspending award obligations are separate public-record systems even when a geography or a calendar year happens to overlap. This packet has no FEC facts. Donations do not fund NIDDK Extramural Research obligations in FY2026.

291 FY2026 awards as a CFDA table, not a clinic census

The extract lists 291 awards on the NIDDK Extramural Research × FY2026 table. That is an award-record count for this yearlyTrend cell, not a census of diabetes or kidney studies. Unique recipients are unpublished. Modifications can add rows without naming a new organization. Dividing $437,079,226.28 by 291 is not published here as a typical award size, because the packet does not say the rows are comparable. The program-wide award count is 7,632, a different denominator.

291 is the award-record count on this FY2026 cell, not a published census of diabetes or kidney studies. Unique vendors and places of performance are unpublished. Do not read 291 as 291 finished projects in NIDDK Extramural Research during FY2026.

Study rankings this 93.847–FY2026 join cannot support

An obligation is a legal commitment. An outlay is a payment. $437,079,226.28 is the former. Citing it as cash already cleared on NIDDK Extramural Research in FY2026 over-reads the field. The join cannot say that NIDDK Extramural Research expanded in FY2026 because of a policy success metric this packet omits. Keep $437,079,226.28 labeled as Diabetes, Digestive, And Kidney Diseases Extramural Research obligations in fiscal year 2026.

Hubs for CFDA 93.847 × FY2026

Open /programs/93.847/ for CFDA 93.847, /fiscal-years/2026/ for FY2026 federal spending, /programs/ (All programs) for other catalog lines, and /ties/ (All spending ties) for other pairs. None of those links convert this cell into a campus ranking or a named NIDDK-grantee list, into outlays this packet omits, or into a contractor list. Cite both sides: Diabetes, Digestive, And Kidney Diseases Extramural Research and FY2026, $437,079,226.28, USAspending.gov, obligations only.

Questions

How much did NIDDK Extramural Research obligate in FY2026?
USAspending.gov records $437,079,226.28 in Diabetes, Digestive, And Kidney Diseases Extramural Research obligations for fiscal year 2026 (CFDA 93.847) across 291 awards. That is an obligation aggregate for the pair, not an outlay and not the program-wide $17,283,124,047.25.
Is NIDDK extramural research in FY2026 an outlay?
No. $437,079,226.28 is an obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for NIDDK Extramural Research in FY2026. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.
Does 291 awards mean 291 diabetes studies in FY2026?
No. 291 is an award-record count for the FY2026 cell, not a census of diabetes or kidney studies. Unique recipients and places of performance are unpublished. The program-wide count is 7,632. Original filings remain on USAspending.gov.
Which pages parent NIDDK Extramural Research and FY2026?
/programs/93.847/ is the program parent. /fiscal-years/2026/ is the FY2026 parent. /programs/ lists programs. /ties/ lists other pairs. Prefer those tables after later ingests; this page quotes NIDDK Extramural Research × FY2026 at $437,079,226.28. Original filings remain on USAspending.gov.

USAspending.gov CFDA program yearlyTrend by fiscal year. Obligations are not outlays.